{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:07:17Z","timestamp":1788916037638,"version":"build-2803163510"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":77,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Talent Support Program of Shaanxi Provincial People\u2019s Hospital","award":["2023JY-27"],"award-info":[{"award-number":["2023JY-27"]}]},{"name":"Leading Talents Program of Shaanxi Provincial People\u2019s Hospital","award":["2021LJ-10"],"award-info":[{"award-number":["2021LJ-10"]}]},{"name":"Shaanxi province innovation ability support plan","award":["2023-CX-TD-74"],"award-info":[{"award-number":["2023-CX-TD-74"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02206-3","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T10:14:31Z","timestamp":1782296071000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Decoding the association between microorganisms and autoimmunity: a multifaceted review of evidence on specific pathogens that trigger autoimmune diseases"],"prefix":"10.1007","volume":"26","author":[{"given":"Haixiang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuixiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"issue":"6","key":"2206_CR1","doi-asserted-by":"publisher","first-page":"103326","DOI":"10.1016\/j.autrev.2023.103326","volume":"22","author":"F Cao","year":"2023","unstructured":"Cao F, He YS, Wang Y, Zha CK, Lu JM, Tao LM, et al. Global burden and cross-country inequalities in autoimmune diseases from 1990 to 2019. Autoimmun Rev. 2023;22(6):103326.","journal-title":"Autoimmun Rev"},{"key":"2206_CR2","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1084\/jem.128.6.1339","volume":"128","author":"R Lagercrantz","year":"1968","unstructured":"Lagercrantz R, Perlmann P, Hammarstrom S. Immunological studies in ulcerative colitis.IV Origin of autoantibodies. J Exp Med. 1968;128:1339\u201352.","journal-title":"J Exp Med"},{"issue":"1","key":"2206_CR3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1084\/jem.166.1.173","volume":"166","author":"PL Sehwimmbeck","year":"1987","unstructured":"Sehwimmbeck PL, Yu DT, Oldstone MB. Autoantibodies to HLA-B27 in the sera of HLA-B27 positive patients with ankylosing spondylitis and Reiter. S syndrome. Molecular mimicry with Klebsiella pneumoniae as potential mechanism of autoimmune disease. J Exp Med. 1987;166(1):173\u201381.","journal-title":"J Exp Med"},{"issue":"294","key":"2206_CR4","doi-asserted-by":"publisher","first-page":"294ra105","DOI":"10.1126\/scitranslmed.aab2354","volume":"7","author":"SS Ahmed","year":"2015","unstructured":"Ahmed SS, Volkmuth W, Duca J, Corti L, Pallaoro M, Pezzicoli A, et al. Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2. Sci Transl Med. 2015;7(294):294ra105.","journal-title":"Sci Transl Med"},{"issue":"8","key":"2206_CR5","doi-asserted-by":"publisher","first-page":"e16365","DOI":"10.1111\/ene.16365","volume":"31","author":"R Bellanti","year":"2024","unstructured":"Bellanti R, Rinaldi S. Guillain-Barr\u00e9syndrome: a comprehensive review. Eur J Neurol. 2024;31(8):e16365.","journal-title":"Eur J Neurol"},{"issue":"21","key":"2206_CR6","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1056\/NEJM199511233332102","volume":"333","author":"JH Rees","year":"1995","unstructured":"Rees JH, Soudain SE, Gregson NA, Hughes RA. Campylobacter jejuni infection and Guillain-Barr\u00e9syndrome. N Engl J Med. 1995;333(21):1374\u20139.","journal-title":"N Engl J Med"},{"issue":"22","key":"2206_CR7","doi-asserted-by":"publisher","first-page":"14222","DOI":"10.3390\/ijms232214222","volume":"23","author":"J Finsterer","year":"2022","unstructured":"Finsterer J. Triggers of Guillain-Barr\u00e9Syndrome: Campylobacter jejuni Predominates. Int J Mol Sci. 2022;23(22):14222.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"2206_CR8","doi-asserted-by":"publisher","first-page":"167315","DOI":"10.1016\/j.bbadis.2024.167315","volume":"1870","author":"BB B\u00e1ez","year":"2024","unstructured":"B\u00e1ez BB, Bacaglio CR, Prendergast JM, Roz\u00e9s-Salvador V, Sheikh KA, Bianchet M, et al. Tumor necrosis factor\u03b1receptor 1A transduces the inhibitory effect on axon regeneration triggered by IgG anti-ganglioside GD1a antibodies. Biochim Biophys Acta Mol Basis Dis. 2024;1870(7):167315.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1\u20132","key":"2206_CR9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S0165-5728(96)00162-2","volume":"73","author":"NA Gregson","year":"1997","unstructured":"Gregson NA, Rees JH, Hughes RA. Reactivity of serum IgG anti-GM1 ganglioside antibodies with the lipopolysaccharide fractions of Campylobacter jejuni isolates from patients with Guillain-Barre syndrome (GBS). J Neuroimmunol. 1997;73(1\u20132):28\u201336.","journal-title":"J Neuroimmunol"},{"issue":"4","key":"2206_CR10","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.it.2022.02.003","volume":"43","author":"JD Laman","year":"2022","unstructured":"Laman JD, Huizinga R, Boons GJ, Jacobs BC. Guillain-Barr\u00e9 syndrome: expanding the concept of molecular mimicry. Trends Immunol. 2022;43(4):296\u2013308.","journal-title":"Trends Immunol"},{"issue":"31","key":"2206_CR11","doi-asserted-by":"publisher","first-page":"11404","DOI":"10.1073\/pnas.0402391101","volume":"101","author":"N Yuki","year":"2004","unstructured":"Yuki N, Susuki K, Koga M, Nishimoto Y, Odaka M, Hirata K, et al. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome. Proc Natl Acad Sci U S A. 2004;101(31):11404\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2206_CR12","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/ana.1012","volume":"49","author":"N Yuki","year":"2001","unstructured":"Yuki N, Yamada M, Koga M, Odaka M, Susuki K, Tagawa Y, et al. Animal model of axonal Guillain-Barr\u00e9syndrome induced by sensitization with GM1 ganglioside. Ann Neurol. 2001;49(6):712\u201320.","journal-title":"Ann Neurol"},{"issue":"7","key":"2206_CR13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2183\/pjab.88.299","volume":"88","author":"N Yuki","year":"2012","unstructured":"Yuki N. Guillain-Barr\u00e9syndrome and anti-ganglioside antibodies: a clinician-scientist\u2019s journey. Proc Jpn Acad Ser B Phys Biol Sci. 2012;88(7):299\u2013326.","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"2206_CR14","doi-asserted-by":"crossref","unstructured":"Shahrizaila N, Yuki N. Guillain-barr\u00e9 syndrome animal model: the first proof of molecular mimicry in human autoimmune disorder. J Biomed Biotechnol. 2011; 2011: 829129.","DOI":"10.1155\/2011\/829129"},{"issue":"7","key":"2206_CR15","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1080\/08916930500285352","volume":"38","author":"G Zandman-Goddard","year":"2005","unstructured":"Zandman-Goddard G, Shoenfeld Y. Infections and SLE. Autoimmunity. 2005;38(7):473\u201385.","journal-title":"Autoimmunity"},{"issue":"3","key":"2206_CR16","first-page":"153","volume":"158","author":"R Illescas-Montes","year":"2019","unstructured":"Illescas-Montes R, Corona-Castro CC, Melguizo-Rodr\u00edguez L, Ruiz C, Costela-Ruiz VJ. Infect processes systemic lupus erythematosus Immunol. 2019;158(3):153\u201360.","journal-title":"Infect processes systemic lupus erythematosus Immunol"},{"key":"2206_CR17","doi-asserted-by":"publisher","first-page":"109122","DOI":"10.1016\/j.biopha.2019.109122","volume":"117","author":"Q Pan","year":"2019","unstructured":"Pan Q, Liu Z, Liao S, Ye L, Lu X, Chen X, et al. Current mechanistic insights into the role of infection in systemic lupus erythematosus. Biomed Pharmacother. 2019;117:109122.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"2206_CR18","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/1529-0131(200105)44:5<1122::AID-ANR193>3.0.CO;2-D","volume":"44","author":"JA James","year":"2001","unstructured":"James JA, Neas BR, Moser KL, Hall T, Bruner GR, Sestak AL, et al. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum. 2001;44(5):1122\u20136.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"2206_CR19","doi-asserted-by":"publisher","first-page":"R295","DOI":"10.1186\/ar1181","volume":"6","author":"UY Moon","year":"2004","unstructured":"Moon UY, Park SJ, Oh ST, Kim WU, Park SH, Lee SH, et al. Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood. Arthritis Res Ther. 2004;6(4):R295\u2013302.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"2206_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10238-018-0535-0","volume":"19","author":"ZX Li","year":"2019","unstructured":"Li ZX, Zeng S, Wu HX, Zhou Y. The risk of systemic lupus erythematosus associated with Epstein-Barr virus infection: a systematic review and meta-analysis. Clin Exp Med. 2019;19(1):23\u201336.","journal-title":"Clin Exp Med"},{"issue":"1","key":"2206_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nm1167","volume":"11","author":"MT McClain","year":"2005","unstructured":"McClain MT, Heinlen LD, Dennis GJ, Roebuck J, Harley JB, James JA. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med. 2005;11(1):85\u20139.","journal-title":"Nat Med"},{"issue":"5","key":"2206_CR22","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1002\/eji.1830230525","volume":"23","author":"A Sabbatini","year":"1993","unstructured":"Sabbatini A, Bombardieri S, Migliorini P. Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA I. Eur J Immunol. 1993;23(5):1146\u201352.","journal-title":"Eur J Immunol"},{"issue":"1","key":"2206_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/08916930500484849","volume":"39","author":"BD Poole","year":"2006","unstructured":"Poole BD, Scofield RH, Harley JB, James JA. Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus. Autoimmunity. 2006;39(1):63\u201370.","journal-title":"Autoimmunity"},{"issue":"2","key":"2206_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jaut.2004.06.001","volume":"23","author":"K Sundar","year":"2004","unstructured":"Sundar K, Jacques S, Gottlieb P, Villars R, Benito ME, Taylor DK, et al. Expression of the Epstein-Barr virus nuclear antigen-1 (EBNA-1) in the mouse can elicit the production of anti-dsDNA and anti-Sm antibodies. J Autoimmun. 2004;23(2):127\u201340.","journal-title":"J Autoimmun"},{"issue":"1","key":"2206_CR25","doi-asserted-by":"publisher","first-page":"010404","DOI":"10.7189\/jogh.10.010404","volume":"10","author":"JR Winter","year":"2020","unstructured":"Winter JR, Jackson C, Lewis JE, Taylor GS, Thomas OG, Stagg HR. Predictors of Epstein-Barr virus serostatus and implications for vaccine policy: A systematic review of the literature. J Glob Health. 2020;10(1):010404.","journal-title":"J Glob Health"},{"issue":"2","key":"2206_CR26","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3390\/v13020277","volume":"13","author":"M Quaglia","year":"2021","unstructured":"Quaglia M, Merlotti G, De Andrea M, Borgogna C, Cantaluppi V. Viral Infections and Systemic Lupus Erythematosus: New Players in an Old Story. Viruses. 2021;13(2):277.","journal-title":"Viruses"},{"issue":"4","key":"2206_CR27","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jaut.2008.08.007","volume":"31","author":"BD Poole","year":"2008","unstructured":"Poole BD, Gross T, Maier S, Harley JB, James JA. Lupus-like autoantibody development in rabbits and mice after immunization with EBNA-1 fragments. J Autoimmun. 2008;31(4):362\u201371.","journal-title":"J Autoimmun"},{"key":"2206_CR28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.molimm.2021.01.013","volume":"132","author":"D Singh","year":"2021","unstructured":"Singh D, Oudit O, Hajtovic S, Sarbaugh D, Salis R, Adebowale T, et al. Antibodies to an Epstein Barr Virus protein that cross-react with dsDNA have pathogenic potential. Mol Immunol. 2021;132:41\u201352.","journal-title":"Mol Immunol"},{"issue":"18","key":"2206_CR29","doi-asserted-by":"publisher","first-page":"e195374","DOI":"10.1172\/JCI195374","volume":"135","author":"J Li","year":"2025","unstructured":"Li J, Kuhn KA. Microbial threads in the tapestry of rheumatoid arthritis. J Clin Invest. 2025;135(18):e195374.","journal-title":"J Clin Invest"},{"issue":"1","key":"2206_CR30","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/BOR.0b013e328333b9f5","volume":"22","author":"J Becker","year":"2010","unstructured":"Becker J, Winthrop KL. Update on rheumatic manifestations of infectious diseases. Curr Opin Rheumatol. 2010;22(1):72\u20137.","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"2206_CR31","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/j.1365-2249.2004.02704.x","volume":"139","author":"M Yamazaki","year":"2005","unstructured":"Yamazaki M, Kitamura R, Kusano S, Eda H, Sato S, Okawa-Takatsuji M, et al. Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein-Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sj\u00f6gren\u2019s syndrome patients with pulmonary involvements. Clin Exp Immunol. 2005;139(3):558\u201368.","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"2206_CR32","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1002\/art.10933","volume":"48","author":"N Balandraud","year":"2003","unstructured":"Balandraud N, Meynard JB, Auger I, Sovran H, Mugnier B, Reviron D, et al. Epstein-Barr virus load in the peripheral blood of patients with rheumatoid arthritis: accurate quantification using real-time polymerase chain reaction. Arthritis Rheum. 2003;48(5):1223\u20138.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2206_CR33","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s40744-022-00427-y","volume":"9","author":"J Zhuo","year":"2022","unstructured":"Zhuo J, Xia Q, Sharma N, Gao S, Lama S, Cui J, et al. The Role of Shared Epitope in Rheumatoid Arthritis Prognosis in Relation to Anti-Citrullinated Protein Antibody Positivity. Rheumatol Ther. 2022;9(2):637\u201347.","journal-title":"Rheumatol Ther"},{"issue":"7","key":"2206_CR34","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1002\/1529-0131(199907)42:7<1485::AID-ANR24>3.0.CO;2-7","volume":"42","author":"JG Saal","year":"1999","unstructured":"Saal JG, Krimmel M, Steidle M, Gerneth F, Wagner S, Fritz P, et al. Synovial Epstein-Barr virus infection increases the risk of rheumatoid arthritis in individuals with the shared HLA-DR4 epitope. Arthritis Rheum. 1999;42(7):1485\u201396.","journal-title":"Arthritis Rheum"},{"issue":"20","key":"2206_CR35","doi-asserted-by":"publisher","first-page":"eadg3032","DOI":"10.1126\/sciadv.adg3032","volume":"9","author":"OG Thomas","year":"2023","unstructured":"Thomas OG, Bronge M, Tengvall K, Akpinar B, Nilsson OB, Holmgren E, et al. Cross-reactive EBNA1 immunity targets alpha-crystallin B and is associated with multiple sclerosis. Sci Adv. 2023;9(20):eadg3032.","journal-title":"Sci Adv"},{"issue":"1","key":"2206_CR36","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13075-016-1031-0","volume":"18","author":"L Johansson","year":"2016","unstructured":"Johansson L, Pratesi F, Brink M, \u00c4rlestig L, D\u2019Amato C, Bartaloni D, et al. Antibodies directed against endogenous and exogenous citrullinated antigens pre-date the onset of rheumatoid arthritis. Arthritis Res Ther. 2016;18(1):127.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"2206_CR37","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.berh.2008.09.007","volume":"22","author":"E Toussirot","year":"2008","unstructured":"Toussirot E, Roudier J. Epstein-Barr virus in autoimmune diseases. Best Pract Res Clin Rheumatol. 2008;22(5):883\u201396.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"10","key":"2206_CR38","doi-asserted-by":"publisher","first-page":"e26630","DOI":"10.1371\/journal.pone.0026630","volume":"6","author":"Y Kuwana","year":"2011","unstructured":"Kuwana Y, Takei M, Yajima M, Imadome K, Inomata H, Shiozaki M, et al. Epstein-Barr virus induces erosive arthritis in humanized mice. PLoS ONE. 2011;6(10):e26630.","journal-title":"PLoS ONE"},{"issue":"2","key":"2206_CR39","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1902\/jop.2009.090309","volume":"81","author":"A Dissick","year":"2010","unstructured":"Dissick A, Redman RS, Jones M, Rangan BV, Reimold A, Griffiths GR, et al. Association of periodontitis with rheumatoid arthritis: a pilot study. J Periodontol. 2010;81(2):223\u201330.","journal-title":"J Periodontol"},{"issue":"5","key":"2206_CR40","doi-asserted-by":"publisher","first-page":"R222","DOI":"10.1186\/ar4061","volume":"14","author":"M de Smit","year":"2012","unstructured":"de Smit M, Westra J, Vissink A, Doornbos-van der Meer B, Brouwer E, van Winkelhoff AJ. Periodontitis in established rheumatoid arthritis patients: a cross-sectional clinical, microbiological and serological study. Arthritis Res Ther. 2012;14(5):R222.","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"2206_CR41","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1002\/art.23936","volume":"58","author":"K Lundberg","year":"2008","unstructured":"Lundberg K, Kinloch A, Fisher BA, Wegner N, Wait R, Charles P, et al. Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum. 2008;58(10):3009\u201319.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"2206_CR42","doi-asserted-by":"publisher","first-page":"e1003627","DOI":"10.1371\/journal.ppat.1003627","volume":"9","author":"KJ Maresz","year":"2013","unstructured":"Maresz KJ, Hellvard A, Sroka A, Adamowicz K, Bielecka E, Koziel J, et al. Porphyromonas gingivalis facilitates the development and progression of destructive arthritis through its unique bacterial peptidylarginine deiminase (PAD). PLoS Pathog. 2013;9(9):e1003627.","journal-title":"PLoS Pathog"},{"key":"2206_CR43","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jns.2018.08.020","volume":"393","author":"D Jakimovski","year":"2018","unstructured":"Jakimovski D, Weinstock-Guttman B, Hagemeier J, Vaughn CB, Kavak KS, Gandhi S, et al. Walking disability measures in multiple sclerosis patients: Correlations with MRI-derived global and microstructural damage. J Neurol Sci. 2018;393:128\u201334.","journal-title":"J Neurol Sci"},{"key":"2206_CR44","doi-asserted-by":"publisher","first-page":"106151","DOI":"10.1016\/j.msard.2024.106151","volume":"92","author":"S Jette","year":"2024","unstructured":"Jette S, de Schaetzen C, Tsai CC, Tremlett H. The multiple sclerosis gut microbiome and disease activity:A systematic review. Mult Scler Relat Disord. 2024;92:106151.","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"2206_CR45","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/ana.21117","volume":"61","author":"A Ascherio","year":"2007","unstructured":"Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol. 2007;61(4):288\u201399.","journal-title":"Ann Neurol"},{"issue":"6","key":"2206_CR46","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/ana.21978","volume":"67","author":"LI Levin","year":"2010","unstructured":"Levin LI, Munger KL, O\u2019Reilly EJ, Falk KI, Ascherio A. Primary infection with the Epstein - Barr virus and risk of multiple sclerosis. Ann Neurol. 2010;67(6):824\u201330.","journal-title":"Ann Neurol"},{"issue":"8","key":"2206_CR47","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1084\/jem.20072397","volume":"205","author":"JD L\u00fcnemann","year":"2008","unstructured":"L\u00fcnemann JD, Jelci\u0107 I, Roberts S, Lutterotti A, Tackenberg B, Martin R, et al. EBNA1 - specific T cells from patients with multiple sclerosis cross - react with myelin antigens and co - produce IFN - gamma and IL\u2009\u2013\u20092. J Exp Med. 2008;205(8):1763\u201373.","journal-title":"J Exp Med"},{"issue":"10","key":"2206_CR48","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/ni835","volume":"3","author":"HL Lang","year":"2002","unstructured":"Lang HL, Jacobsen H, Ikemizu S, Andersson C, Harlos K, Madsen L, et al. A functional and structural basis for TCR cross - reactivity in multiple sclerosis. Nat Immunol. 2002;3(10):940\u20133.","journal-title":"Nat Immunol"},{"issue":"3","key":"2206_CR49","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1080\/13550280490499524","volume":"10","author":"T Holmoy","year":"2004","unstructured":"Holmoy T, Kvale EO, Vartdal F. Cerebrospinal fluid CD4\u2009+\u2009T cells from a multiple sclerosis patient cross-recognize Epstein-Barr virus and myelin basic protein. J Neurovirol. 2004;10(3):278\u201383.","journal-title":"J Neurovirol"},{"issue":"7","key":"2206_CR50","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.it.2017.04.006","volume":"38","author":"J Geginat","year":"2017","unstructured":"Geginat J, Paroni M, Pagani M, Galimberti D, De Francesco R, Scarpini E, et al. The Enigmatic Role of Viruses in Multiple Sclerosis: Molecular Mimicry or Disturbed Immune Surveillance? Trends Immunol. 2017;38(7):498\u2013512.","journal-title":"Trends Immunol"},{"issue":"2","key":"2206_CR51","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1172\/JCI200113032","volume":"108","author":"JK Olson","year":"2001","unstructured":"Olson JK, Croxford JL, Calenoff MA, Dal Canto MC, Miller SD. A virus-induced molecular mimicry model of multiple sclerosis. J Clin Invest. 2001;108(2):311\u20138.","journal-title":"J Clin Invest"},{"issue":"13","key":"2206_CR52","doi-asserted-by":"publisher","first-page":"8581","DOI":"10.1128\/JVI.79.13.8581-8590.2005","volume":"79","author":"JL Croxford","year":"2005","unstructured":"Croxford JL, Olson JK, Anger HA, Miller SD. Initiation and exacerbation of autoimmune demyelination of the central nervous system via virus-induced molecular mimicry: implications for the pathogenesis of multiple sclerosis. J Virol. 2005;79(13):8581\u201390.","journal-title":"J Virol"},{"issue":"11","key":"2206_CR53","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41584-024-01167-9","volume":"20","author":"WH Robinson","year":"2024","unstructured":"Robinson WH, Younis S, Love ZZ, Steinman L, Lanz TV. Epstein-Barr virus as a potentiator of autoimmune diseases. Nat Rev Rheumatol. 2024;20(11):729\u201340.","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"2206_CR54","doi-asserted-by":"publisher","first-page":"e70016","DOI":"10.1111\/sji.70016","volume":"101","author":"A Munir","year":"2025","unstructured":"Munir A, Khan S, Saleem A, Nusrat H, Khan SA, Sayyed H, et al. The Role of Epstein-Barr Virus Molecular Mimicry in Various Autoimmune Diseases. Scand J Immunol. 2025;101(4):e70016.","journal-title":"Scand J Immunol"},{"issue":"11","key":"2206_CR55","doi-asserted-by":"publisher","first-page":"e2519445123","DOI":"10.1073\/pnas.2519445123","volume":"123","author":"FM Lum","year":"2026","unstructured":"Lum FM, Sattarnezhad N, Ho PP, Orr N, Robinson WH, Lanz TV, et al. Multiple molecular mimics in Epstein Barr Nuclear Antigen-1, and the pathogenesis of multiple sclerosis. Proc Natl Acad Sci U S A. 2026;123(11):e2519445123.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"824","key":"2206_CR56","doi-asserted-by":"publisher","first-page":"eady0210","DOI":"10.1126\/scitranslmed.ady0210","volume":"17","author":"S Younis","year":"2025","unstructured":"Younis S, Moutusy SI, Rasouli S, Jahanbani S, Pandit M, Wu X, et al. Epstein-Barr virus reprograms autoreactive B cells as antigen-presenting cells in systemic lupus erythematosus. Sci Transl Med. 2025;17(824):eady0210.","journal-title":"Sci Transl Med"},{"issue":"2","key":"2206_CR57","doi-asserted-by":"publisher","first-page":"e70153","DOI":"10.1002\/eji.70153","volume":"56","author":"F L\u00e4derach","year":"2026","unstructured":"L\u00e4derach F, Bremer E, M\u00fcnz C. Latent, Lytic, and Linked to Multiple Sclerosis-How EBV Drives Autoimmunity. Eur J Immunol. 2026;56(2):e70153.","journal-title":"Eur J Immunol"},{"issue":"1","key":"2206_CR58","doi-asserted-by":"publisher","first-page":"2180951","DOI":"10.1080\/21505594.2023.2180951","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Zhou X, Chen S, Sun X, Zhou C. Immune mechanisms of group B coxsackievirus induced viral myocarditis. Virulence. 2023;14(1):2180951.","journal-title":"Virulence"},{"issue":"6","key":"2206_CR59","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.jgg.2024.02.007","volume":"51","author":"H Du","year":"2024","unstructured":"Du H, Du Z, Wang L, Wang H, Jia M, Zhang C, et al. Fulminant myocarditis induced by SARS-CoV-2 infection without severe lung involvement: insights into COVID-19 pathogenesis. J Genet Genomics. 2024;51(6):608\u201316.","journal-title":"J Genet Genomics"},{"issue":"1","key":"2206_CR60","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1128\/CMR.19.1.80-94.2006","volume":"19","author":"RS Fujinami","year":"2006","unstructured":"Fujinami RS, von Herrath MG, Christen U, Whitton JL. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev. 2006;19(1):80\u201394.","journal-title":"Clin Microbiol Rev"},{"issue":"7","key":"2206_CR61","first-page":"1055","volume":"11","author":"MT Rasquinha","year":"2022","unstructured":"Rasquinha MT, Lasrado N, Petro-Turnquist E, Weaver E, Venkataraman T, Anderson D, et al. PhIP-Seq Reveals Autoantibodies for Ubiquitously Expressed Antigens in Viral Myocarditis. Biology (Basel). 2022;11(7):1055.","journal-title":"Biology (Basel)"},{"issue":"8642","key":"2206_CR62","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S0140-6736(89)92270-8","volume":"1","author":"P Muir","year":"1989","unstructured":"Muir P, Nicholson F, Tilzey AJ, Signy M, English TA, Banatvala JE. Chronic relapsing pericarditis and dilated cardiomyopathy: serological evidence of persistent enterovirus infection. Lancet. 1989;1(8642):804\u20137.","journal-title":"Lancet"},{"issue":"Suppl O","key":"2206_CR63","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/eurheartj\/16.suppl_O.64","volume":"16","author":"K Schulze","year":"1995","unstructured":"Schulze K, Schultheiss HP. The role of the ADP\/ATP carrier in the pathogenesis of viral heart disease. Eur Heart J. 1995;16(Suppl O):64\u20137.","journal-title":"Eur Heart J"},{"issue":"9","key":"2206_CR64","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1007\/s11427-022-2273-3","volume":"66","author":"W He","year":"2023","unstructured":"He W, Zhou L, Xu K, Li H, Wang JJ, Chen C, et al. Immunopathogenesis and immunomodulatory therapy for myocarditis. Sci China Life Sci. 2023;66(9):2112\u201337.","journal-title":"Sci China Life Sci"},{"issue":"1","key":"2206_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08916930802208540","volume":"42","author":"R Root-Bernstein","year":"2009","unstructured":"Root-Bernstein R, Vonck J, Podufaly A. Antigenic complementarity between coxsackie virus and streptococcus in the induction of rheumatic heart disease and autoimmune myocarditis. Autoimmunity. 2009;42(1):1\u201316.","journal-title":"Autoimmunity"},{"issue":"2","key":"2206_CR66","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ijcard.2014.09.136","volume":"177","author":"C Massilamany","year":"2014","unstructured":"Massilamany C, Gangaplara A, Reddy J. Intricacies of cardiac damage in coxsackievirus B3 infection: implications for therapy. Int J Cardiol. 2014;177(2):330\u20139.","journal-title":"Int J Cardiol"},{"issue":"5","key":"2206_CR67","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1084\/jem.161.5.1112","volume":"161","author":"LJ Wolfgram","year":"1985","unstructured":"Wolfgram LJ, Beisel KW, Rose NR. Heart-specific autoantibodies following murine coxsackievirus B3 myocarditis. J Exp Med. 1985;161(5):1112\u201321.","journal-title":"J Exp Med"},{"issue":"6","key":"2206_CR68","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.4049\/jimmunol.154.6.2983","volume":"154","author":"CJ Gauntt","year":"1995","unstructured":"Gauntt CJ, Arizpe HM, Higdon AL, Wood HJ, Bowers DF, Rozek MM, et al. Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies, and myocarditis. J Immunol. 1995;154(6):2983\u201395.","journal-title":"J Immunol"},{"issue":"3","key":"2206_CR69","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.clim.2012.07.003","volume":"144","author":"A Gangaplara","year":"2012","unstructured":"Gangaplara A, Massilamany C, Brown DM, Delhon G, Pattnaik AK, Chapman N, et al. Coxsackievirus B3 infection leads to the generation of cardiac myosin heavy chain-\u03b1-reactive CD4 T cells in A\/J mice. Clin Immunol. 2012;144(3):237\u201349.","journal-title":"Clin Immunol"},{"key":"2206_CR70","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1056\/NEJM189905181402001","volume":"140","author":"HF Harris","year":"1899","unstructured":"Harris HF. A case of diabetes mellitus quickly following mumps. Bost Med Surg J. 1899;140:465\u20139.","journal-title":"Bost Med Surg J"},{"issue":"3","key":"2206_CR71","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/pedi.12957","volume":"21","author":"MAM Rogers","year":"2020","unstructured":"Rogers MAM, Kim C. Congenital infections as contributors to the onset of diabetes in children: A longitudinal study in the United States, 2001\u20132017. Pediatr Diabetes. 2020;21(3):456\u20139.","journal-title":"Pediatr Diabetes"},{"key":"2206_CR72","doi-asserted-by":"crossref","unstructured":"Laiho JE, Oikarinen S, Morfopoulou S, Oikarinen M, Renner A, Depledge D et al. Detection of enterovirus RNA in pancreas and lymphoid tissues of organ donors with type 1 diabetes. Diabetologia. 2025;68(6):1211-25.","DOI":"10.1007\/s00125-025-06359-w"},{"issue":"1","key":"2206_CR73","doi-asserted-by":"publisher","first-page":"7630","DOI":"10.1038\/s41467-023-42763-9","volume":"14","author":"J Lin","year":"2023","unstructured":"Lin J, Moradi E, Salenius K, Lehtipuro S, H\u00e4kkinen T, Laiho JE, et al. Distinct transcriptomic profiles in children prior to the appearance of type 1 diabetes-linked islet autoantibodies and following enterovirus infection. Nat Commun. 2023;14(1):7630.","journal-title":"Nat Commun"},{"issue":"3","key":"2206_CR74","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/jmv.2151","volume":"66","author":"T H\u00e4rk\u00f6nen","year":"2002","unstructured":"H\u00e4rk\u00f6nen T, Lankinen H, Davydova B, Hovi T, Roivainen M. Enterovirus infection can induce immune responses that cross-react with beta-cell autoantigen tyrosine phosphatase IA-2\/IAR. J Med Virol. 2002;66(3):340\u201350.","journal-title":"J Med Virol"},{"issue":"3","key":"2206_CR75","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1046\/j.1365-2249.1996.60771.x","volume":"104","author":"M L\u00f6nnrot","year":"1996","unstructured":"L\u00f6nnrot M, Hy\u00f6ty H, Knip M, Roivainen M, Kulmala P, Leinikki P, et al. Antibody cross-reactivity induced by the homologous regions in glutamic acid decarboxylase (GAD65) and 2\u00a0C protein of coxsackievirus B4. Childhood Diabetes in Finland Study Group. Clin Exp Immunol. 1996;104(3):398\u2013405.","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"2206_CR76","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1093\/infdis\/171.5.1131","volume":"171","author":"DM See","year":"1995","unstructured":"See DM, Tilles JG. Pathogenesis of virus-induced diabetes in mice. J Infect Dis. 1995;171(5):1131\u20138.","journal-title":"J Infect Dis"},{"issue":"1","key":"2206_CR77","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s001250050864","volume":"41","author":"GR Vreugdenhil","year":"1998","unstructured":"Vreugdenhil GR, Geluk A, Ottenhoff TH, Melchers WJ, Roep BO, Galama JM. Molecular mimicry in diabetes mellitus: the homologous domain in coxsackie B virus protein 2\u00a0C and islet autoantigen GAD65 is highly conserved in the coxsackie B-like enteroviruses and binds to the diabetes associated HLA-DR3 molecule. Diabetologia. 1998;41(1):40\u20136.","journal-title":"Diabetologia"},{"issue":"7","key":"2206_CR78","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nm0798-781","volume":"4","author":"MS Horwitz","year":"1998","unstructured":"Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvetnick N. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med. 1998;4(7):781\u20135.","journal-title":"Nat Med"},{"issue":"6","key":"2206_CR79","doi-asserted-by":"publisher","first-page":"867","DOI":"10.4254\/wjh.v16.i6.867","volume":"16","author":"J Soldera","year":"2024","unstructured":"Soldera J. Immunological crossroads: The intriguing dance between hepatitis C and autoimmune hepatitis. World J Hepatol. 2024;16(6):867\u201370.","journal-title":"World J Hepatol"},{"issue":"1","key":"2206_CR80","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1740-2557-1-2","volume":"1","author":"K Zachou","year":"2004","unstructured":"Zachou K, Rigopoulou E, Dalekos GN. Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease. J Autoimmune Dis. 2004;1(1):2.","journal-title":"J Autoimmune Dis"},{"issue":"3","key":"2206_CR81","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/hep.20816","volume":"42","author":"G Marceau","year":"2005","unstructured":"Marceau G, Lapierre P, Beland K, Soudeyns H, Alvarez F. LKM1 autoantibodies in chronic hepatitis C infection: a case of molecular mimicry? Hepatology. 2005;42(3):675\u201382.","journal-title":"Hepatology"},{"issue":"2","key":"2206_CR82","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1084\/jem.190.2.169","volume":"190","author":"AR Kammer","year":"1999","unstructured":"Kammer AR, van der Burg SH, Grabscheid B, Hunziker IP, Kwappenberg KM, Reichen J, et al. Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition. J Exp Med. 1999;190(2):169\u201376.","journal-title":"J Exp Med"},{"issue":"3","key":"2206_CR83","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jaut.2011.06.005","volume":"37","author":"E Hintermann","year":"2011","unstructured":"Hintermann E, Holdener M, Bayer M, Loges S, Pfeilschifter JM, Granier C, et al. Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model. J Autoimmun. 2011;37(3):242\u201353.","journal-title":"J Autoimmun"},{"issue":"6","key":"2206_CR84","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1084\/jem.20071859","volume":"205","author":"M Holdener","year":"2008","unstructured":"Holdener M, Hintermann E, Bayer M, Rhode A, Rodrigo E, Hintereder G, et al. Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection. J Exp Med. 2008;205(6):1409\u201322.","journal-title":"J Exp Med"},{"key":"2206_CR85","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jaut.2012.11.001","volume":"42","author":"J Ehser","year":"2013","unstructured":"Ehser J, Holdener M, Christen S, Bayer M, Pfeilschifter JM, Hintermann E, et al. Molecular mimicry rather than identity breaks T-cell tolerance in the CYP2D6 mouse model for human autoimmune hepatitis. J Autoimmun. 2013;42:39\u201349.","journal-title":"J Autoimmun"},{"issue":"3","key":"2206_CR86","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.3928\/19382359-20210221-01","volume":"50","author":"SR de Loizaga","year":"2021","unstructured":"de Loizaga SR, Beaton AZ. Rheumatic Fever and Rheumatic Heart Disease in the United States. Pediatr Ann. 2021;50(3):e98\u2013104.","journal-title":"Pediatr Ann"},{"issue":"5","key":"2206_CR87","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1542\/pir.2019-0288","volume":"42","author":"S Lahiri","year":"2021","unstructured":"Lahiri S, Sanyahumbi A. Acute Rheumatic Fever. Pediatr Rev. 2021;42(5):221\u201332.","journal-title":"Pediatr Rev"},{"issue":"4","key":"2206_CR88","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1084\/jem.124.4.661","volume":"124","author":"JB Zabriskie","year":"1966","unstructured":"Zabriskie JB, Freimer EH. An immunological relationship between the group A streptococcus and mammalian muscle. J Exp Med. 1966;124(4):661\u201378.","journal-title":"J Exp Med"},{"issue":"4","key":"2206_CR89","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1084\/jem.119.4.651","volume":"119","author":"MH Kaplan","year":"1964","unstructured":"Kaplan MH, Svec KH. Immunologic relation of streptococcal and tissue antigens. III. Presence in human sera of streptococcal antibody cross reactive with heart tissue. Association with streptococcal infection, rheumatic fever, and glomerulonephritis. J Exp Med. 1964;119(4):651\u201366.","journal-title":"J Exp Med"},{"issue":"8","key":"2206_CR90","doi-asserted-by":"publisher","first-page":"5448","DOI":"10.4049\/jimmunol.175.8.5448","volume":"175","author":"NM Ellis","year":"2005","unstructured":"Ellis NM, Li Y, Hildebrand W, Fischetti VA, Cunningham MW. T cell mimicry and epitope specificity of cross-reactive T cell clones from rheumatic heart disease. J Immunol. 2005;175(8):5448\u201356.","journal-title":"J Immunol"},{"issue":"6","key":"2206_CR91","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1128\/IAI.69.6.4072-4078.2001","volume":"69","author":"A Quinn","year":"2001","unstructured":"Quinn A, Kosanke S, Fischetti VA, Factor SM, Cunningham MW. Induction of autoimmune valvular heart disease by recombinant streptococcal m protein. Infect Immun. 2001;69(6):4072\u20138.","journal-title":"Infect Immun"},{"issue":"2","key":"2206_CR92","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s12265-013-9526-4","volume":"7","author":"CA Kirvan","year":"2014","unstructured":"Kirvan CA, Galvin JE, Hilt S, Kosanke S, Cunningham MW. Identification of streptococcal m-protein cardiopathogenic epitopes in experimental autoimmune valvulitis. J Cardiovasc Transl Res. 2014;7(2):172\u201381.","journal-title":"J Cardiovasc Transl Res"},{"issue":"8","key":"2206_CR93","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1080\/08916934.2016.1217999","volume":"49","author":"D Gorton","year":"2016","unstructured":"Gorton D, Sikder S, Williams NL, Chilton L, Rush CM, Govan BL, et al. Repeat exposure to group A streptococcal M protein exacerbates cardiac damage in a rat model of rheumatic heart disease. Autoimmunity. 2016;49(8):563\u201370.","journal-title":"Autoimmunity"},{"issue":"2","key":"2206_CR94","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1080\/08916934.2019.1605356","volume":"52","author":"S Sikder","year":"2019","unstructured":"Sikder S, Price G, Alim MA, Gautam A, Scott Simpson R, Margaret Rush C, et al. Group A streptococcal M-protein specific antibodies and T-cells drive the pathology observed in the rat autoimmune valvulitis model. Autoimmunity. 2019;52(2):78\u201387.","journal-title":"Autoimmunity"},{"key":"2206_CR95","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3389\/fimmu.2020.00766","volume":"11","author":"L Wang","year":"2020","unstructured":"Wang L, Wang R, Xu C, Zhou H. Pathogenesis of Herpes Stromal Keratitis: Immune Inflammatory Response Mediated by Inflammatory Regulators. Front Immunol. 2020;11:766.","journal-title":"Front Immunol"},{"issue":"1","key":"2206_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00003226-200101000-00001","volume":"20","author":"TJ Liesegang","year":"2001","unstructured":"Liesegang TJ. Herpes simplex virus epidemiology and ocular importance. Cornea. 2001;20(1):1\u201313.","journal-title":"Cornea"},{"issue":"6539","key":"2206_CR97","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/376431a0","volume":"376","author":"AC Avery","year":"1995","unstructured":"Avery AC, Zhao ZS, Rodriguez A, Bikoff EK, Soheilian M, Foster CS, et al. Resistance to herpes stromal keratitis conferred by an IgG2a-derived peptide. Nature. 1995;376(6539):431\u20134.","journal-title":"Nature"},{"issue":"5","key":"2206_CR98","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/08916930410001713106","volume":"37","author":"S Wickham","year":"2004","unstructured":"Wickham S, Carr DJ. Molecular mimicry versus bystander activation: herpetic stromal keratitis. Autoimmunity. 2004;37(5):393\u20137.","journal-title":"Autoimmunity"},{"issue":"5355","key":"2206_CR99","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1126\/science.279.5355.1344","volume":"279","author":"ZS Zhao","year":"1998","unstructured":"Zhao ZS, Granucci F, Yeh L, Schaffer PA, Cantor H. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science. 1998;279(5355):1344\u20137.","journal-title":"Science"},{"issue":"1","key":"2206_CR100","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1086\/504294","volume":"194","author":"CC Tam","year":"2006","unstructured":"Tam CC, Rodrigues LC, Petersen I, Islam A, Hayward A, O\u2018Brien SJ. Incidence of Guillain-Barr\u00e9 syndrome among patients with Campylobacter infection: a general practice research database study. J Infect Dis. 2006;194(1):95\u20137.","journal-title":"J Infect Dis"},{"issue":"6578","key":"2206_CR101","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.abj8222","volume":"375","author":"K Bjornevik","year":"2022","unstructured":"Bjornevik K, Cortese M, Healy BC, Kuhle J, Mina MJ, Leng Y, et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science. 2022;375(6578):296\u2013301.","journal-title":"Science"},{"issue":"1","key":"2206_CR102","doi-asserted-by":"publisher","first-page":"2461072","DOI":"10.1080\/08916934.2025.2461072","volume":"58","author":"L Morel","year":"2025","unstructured":"Morel L. Animal models of autoimmunity: a relentless pursuit of accurate pre-clinical models. Autoimmunity. 2025;58(1):2461072.","journal-title":"Autoimmunity"},{"key":"2206_CR103","doi-asserted-by":"publisher","first-page":"RP99389","DOI":"10.7554\/eLife.99389.3","volume":"13","author":"M Khosravi-Maharlooei","year":"2025","unstructured":"Khosravi-Maharlooei M, Vecchione A, Danzl N, Li HW, Nauman G, Madley R, et al. Follicular helper- and peripheral helper-like T cells drive autoimmune disease in human immune system mice. Elife. 2025;13:RP99389.","journal-title":"Elife"},{"key":"2206_CR104","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40674-025-00235-9","volume":"11","author":"AL Yeo","year":"2025","unstructured":"Yeo AL, Winthrop KL. Risk of Herpes Zoster and Opportunistic Infections with Treatments for Autoimmune Rheumatic Disease. Curr Treat Options Rheumatol. 2025;11:15.","journal-title":"Curr Treat Options Rheumatol"},{"issue":"12","key":"2206_CR105","doi-asserted-by":"publisher","first-page":"103210","DOI":"10.1016\/j.autrev.2022.103210","volume":"21","author":"C Chen","year":"2022","unstructured":"Chen C, Wang P, Zhang RD, Fang Y, Jiang LQ, Fang X, et al. Mendelian randomization as a tool to gain insights into the mosaic causes of autoimmune diseases. Autoimmun Rev. 2022;21(12):103210.","journal-title":"Autoimmun Rev"},{"issue":"4","key":"2206_CR106","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jaut.2007.07.014","volume":"29","author":"KR Ryan","year":"2007","unstructured":"Ryan KR, Patel SD, Stephens LA, Anderton SM. Death, adaptation and regulation: the three pillars of immune tolerance restrict the risk of autoimmune disease caused by molecular mimicry. J Autoimmun. 2007;29(4):262\u201371.","journal-title":"J Autoimmun"},{"key":"2206_CR107","first-page":"102564","volume":"96","author":"M Franco","year":"2025","unstructured":"Franco M, Anaya JM. Autoimmunity, epitope analysis, and molecular mimicry. Curr Opin Immunol. 2025;96:102564.","journal-title":"Curr Opin Immunol"},{"key":"2206_CR108","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jaut.2018.10.012","volume":"95","author":"M Rojas","year":"2018","unstructured":"Rojas M, Restrepo-Jim\u00e9nez P, Monsalve DM, Pacheco Y, Acosta-Ampudia Y, Ram\u00edrez-Santana C, et al. Molecular mimicry and autoimmunity. J Autoimmun. 2018;95:100\u201323.","journal-title":"J Autoimmun"},{"issue":"8","key":"2206_CR109","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3390\/v11080762","volume":"11","author":"MK Smatti","year":"2019","unstructured":"Smatti MK, Cyprian FS, Nasrallah GK, Al Thani AA, Almishal RO, Yassine HM. Viruses and Autoimmunity: A Review on the Potential Interaction and Molecular Mechanisms. Viruses. 2019;11(8):762.","journal-title":"Viruses"},{"issue":"2","key":"2206_CR110","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nri724","volume":"2","author":"CL Vanderlugt","year":"2002","unstructured":"Vanderlugt CL, Miller SD. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat Rev Immunol. 2002;2(2):85\u201395.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2206_CR111","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1172\/JCI0211198","volume":"109","author":"MS Horwitz","year":"2002","unstructured":"Horwitz MS, Ilic A, Fine C, Rodriguez E, Sarvetnick N. Presented antigen from damaged pancreatic beta cells activates autoreactive T cells in virus-mediated autoimmune diabetes. J Clin Invest. 2002;109(1):79\u201387.","journal-title":"J Clin Invest"},{"issue":"1","key":"2206_CR112","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1212\/WNL.0b013e31823ed057","volume":"78","author":"JS Tzartos","year":"2012","unstructured":"Tzartos JS, Khan G, Vossenkamper A, Cruz-Sadaba M, Lonardi S, Sefia E, et al. Association of innate immune activation with latent Epstein-Barr virus in active MS lesions. Neurology. 2012;78(1):15\u201323.","journal-title":"Neurology"},{"key":"2206_CR113","doi-asserted-by":"publisher","first-page":"110266","DOI":"10.1016\/j.clim.2024.110266","volume":"265","author":"S Sartoris","year":"2024","unstructured":"Sartoris S, Del Pozzo G. Exploring the HLA complex in autoimmunity: From the risk haplotypes to the modulation of expression. Clin Immunol. 2024;265:110266.","journal-title":"Clin Immunol"},{"issue":"12","key":"2206_CR114","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1084\/jem.20131241","volume":"210","author":"SW Scally","year":"2013","unstructured":"Scally SW, Petersen J, Law SC, Dudek NL, Nel HJ, Loh KL, et al. A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis. J Exp Med. 2013;210(12):2569\u201382.","journal-title":"J Exp Med"},{"key":"2206_CR115","doi-asserted-by":"publisher","first-page":"104729","DOI":"10.1016\/j.cellimm.2023.104729","volume":"390","author":"AK Moustakas","year":"2023","unstructured":"Moustakas AK, Nguyen H, James EA, Papadopoulos GK. Autoimmune susceptible HLA class II motifs facilitate the presentation of modified neoepitopes to potentially autoreactive T cells. Cell Immunol. 2023;390:104729.","journal-title":"Cell Immunol"},{"issue":"12","key":"2206_CR116","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.3390\/biom14121653","volume":"14","author":"V Chasov","year":"2024","unstructured":"Chasov V, Gilyazova E, Ganeeva I, Zmievskaya E, Davletshin D, Valiullina A, et al. Gut Microbiota Modulation: A Novel Strategy for Rheumatoid Arthritis Therapy. Biomolecules. 2024;14(12):1653.","journal-title":"Biomolecules"},{"key":"2206_CR117","doi-asserted-by":"publisher","first-page":"1482214","DOI":"10.3389\/fimmu.2024.1482214","volume":"15","author":"P Qi","year":"2024","unstructured":"Qi P, Chen X, Tian J, Zhong K, Qi Z, Li M, et al. The gut homeostasis-immune system axis: novel insights into rheumatoid arthritis pathogenesis and treatment. Front Immunol. 2024;15:1482214.","journal-title":"Front Immunol"},{"issue":"4","key":"2206_CR118","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41423-023-00987-1","volume":"20","author":"CH Kim","year":"2023","unstructured":"Kim CH. Complex regulatory effects of gut microbial short-chain fatty acids on immune tolerance and autoimmunity. Cell Mol Immunol. 2023;20(4):341\u201350.","journal-title":"Cell Mol Immunol"},{"issue":"31","key":"2206_CR119","doi-asserted-by":"publisher","first-page":"e2120028119","DOI":"10.1073\/pnas.2120028119","volume":"119","author":"K Girdhar","year":"2022","unstructured":"Girdhar K, Huang Q, Chow IT, Vatanen T, Brady C, Raisingani A, et al. A gut microbial peptide and molecular mimicry in the pathogenesis of type 1 diabetes. Proc Natl Acad Sci U S A. 2022;119(31):e2120028119.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02206-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02206-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02206-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:03:16Z","timestamp":1788915796000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02206-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":119,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2206"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02206-3","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"26 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"322"}}